Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

6.93
-0.0700-1.00%
Post-market: 6.930.00000.00%16:33 EDT
Volume:1.85M
Turnover:12.68M
Market Cap:1.10B
PE:-6.03
High:7.10
Open:7.00
Low:6.69
Close:7.00
Loading ...
Apr 28, 2020

Major Issues Report

8-K - Current report
Apr 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 25, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Major Issues Report

Current report, item 2.05
Sep 24, 2019

Major Issues Report

Current report, item 8.01
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities